期刊文献+

放射性^(32)P敷贴治疗瘢痕疙瘩临床观察 被引量:3

Clinical Observation of Cutaneous Keloid with ^(32)P Application Therapy
下载PDF
导出
摘要 目的探讨放射性32P敷贴治疗瘢痕疙瘩临床疗效,评价其应用价值。方法对840例瘢痕疙瘩病人,采用放射性核素32P药液烘干药纸敷贴于相应病灶表面进行治疗。每月1次,每次5~7 d,平均4~6次敷贴照射。结果平均随访1~3 a,治愈786例(93.57%),显效31例(3.69%),无效23例(2.74%),总有效率97.26%(817/840)。结论放射性32P敷贴治疗皮肤瘢痕疙瘩疗效确切,无不良反应,简便易行,安全,无痛苦,值得临床进一步研究、推广应用。 Objective To explore the clinical effect of cutaneous keloid with ^32P application and its clinical value.Methods A total of 840 cases of cutaneous keloid were treated with radioactive ^32P application in corresponding focus surface.About 4~6 times,every month,the treatment course is 5~7 days.Results 840 patients were followed-up 1~3 years.786 cases were curative(93.57%),31cases became more facile(3.69%),23 cases had no effect(2.74%).The effective rate was 97.26%(817/840).Conclusion The effect of radioactive ^32P is definite and there is no adverse effects.It is simple,easy,safe and painless.It is worthy of further research and expansion in clinical practice.
出处 《河南职工医学院学报》 2011年第1期11-13,共3页 Journal of Henan Medical College For Staff and Workers
关键词 瘢痕疙瘩 放射性32P 敷贴 Keloid Radioactive 32P
  • 相关文献

参考文献2

二级参考文献32

  • 1Ueda,K.,Furuya,E.,Yasuda,Y.,et al.keloid have continuous high metabolic activity.Plast.Reconstr.Surg,1999,104:694-698.
  • 2Tuan,T.L.,Nichter,L.S.The molecular basis of keloid and hypertrophic scar formation.Mol.Med.Today,1998,4:19-24.
  • 3Greenhalgh,D.G.The role of apoptosis in wound healing.Int.J.Biochem.Cell.Biol,1998,30:1019-1030.
  • 4Desmouliere,A.,Redard,M.,Darby,l.,et al.Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar.Am.J.of Pathol,1995,146:56-60.
  • 5Appleton,L.,Brown,N.J.,Willoughby,D.A.Apoptosis,Necrosis,and Proliferation possible implications in the etiology of keloid.Am.J.of Pathol,1996,149:1441-1450.
  • 6Saed,G.M.,Ladin,D.,Olson,J.,et al.Analysis of p53 gene mutation in keloids using polymerase chain reaction-based single-strand conformational polymorphism and DNA sequencing.Arch.Dermatol,1998,134:963-972.
  • 7Teofoli,P.,Barduagni,S.,Ribuffo,M.,et al.Expression of Bcl-2,p53 ,c-jun and c-fos protooncogenes in keloids and hypertrophic scars.J.Dermatol.Sci,1999,22:31-35.
  • 8Akasaka,Y.,Ishikawa,Y.,Ono,I.,et al.Enhanced expression of caspase-3 in hypertrophic scar and keloid:Induction of caspase-3 and apoptosis in keloid fibroblasts in vitro.Lab.Invest,2000,80:345-355.
  • 9Alnemri,E.S.,Livingston,D.J.,Nicholson,D.W.,et al.Human ICE/CED-3 protease nomenclature.Cell,1996,87:171-180.
  • 10Armstrong,RC.,Aja,T.,Xiang,J.,et al.Fas-induced activation of the cell deathrelated protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors.J.Biol.Chem,1996,271:16850-16858.

共引文献41

同被引文献30

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部